Articles From: AMN Healthcare to Host 2014 Second Quarter Earnings Conference Call on Thursday, July 31, 2014 to AmREIT Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Regency Centers


SAN DIEGO , July 3, 2014 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AHS) , healthcare's innovator in workforce solutions and staffing services, will host a conference call to discuss second quarter 2014 results on Thursday, July 31, 2014 at 5:00 p.m. Eastern Time .
Sign-up for AMN Healthcare to Host 2014 Second Quarter Earnings Conference Call on Thursday, July 31, 2014 investment picks
SAN DIEGO , July 15, 2014 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AHS) , healthcare's innovator in workforce solutions and staffing services, is scheduled to participate in the Avondale Partners Healthcare 1-1 Conference on Monday, August 11, 2014 at the Boston Harbor Hotel in Boston , Massachusetts.
Sign-up for AMN Healthcare to Participate in the Avondale Partners Healthcare 1-1 Conference investment picks
SAN DIEGO , Aug.
Sign-up for AMN Healthcare to Present at the Morgan Stanley Global Healthcare Conference investment picks
2014/8/20
Amorfix announces retirement of Dr.
Sign-up for Amorfix announces retirement of Dr. Hans Black investment picks
2014/9/4
Amorfix appoints Dr Elliot Goldstein and Mr Warren Whitehead to Board of Directors Canada NewsWire SOURCE Amorfix Life Sciences Ltd.
Sign-up for Amorfix appoints Dr Elliot Goldstein and Mr Warren Whitehead to Board of Directors investment picks
2014/7/16
Amorfix awarded broad United States patent for misfolded SOD1-targeted treatment of ALS Canada NewsWire TSX: AMF TORONTO , July 16, 2014 /CNW/ - Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that the company has been issued a broad patent covering antibodies that target misfolded SOD1 (mSOD1) for the treatment of ALS.
Sign-up for Amorfix awarded broad United States patent for misfolded SOD1-targeted treatment of ALS investment picks
2014/8/20
By Robb M.
Sign-up for AMP Profit Dips on Accounting-Related Hit investment picks
2014/8/1
Ampco-Pittsburgh Corporation (NYSE: AP) announces sales for the three and six months ended June 30, 2014 of $69,949,000 and $132,862,000, respectively, against $69,938,000 and $139,562,000 for the comparable prior year periods.
Sign-up for Ampco-Pittsburgh Announces Second Quarter Earnings investment picks
2014/6/20
Ampco-Pittsburgh Corporation (NYSE: AP) today announced the declaration of a regular quarterly dividend of eighteen cents ($.18) per share on the common stock of the Corporation.
Sign-up for Ampco-Pittsburgh Corporation Announces Regular Quarterly Dividend investment picks
RANCHO CUCAMONGA, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH) , a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and inhalation products, today announced that the underwriters of its initial public offering exercised in full their option to purchase from Amphastar 1,200,000 additional shares of its common stock at the initial public offering price of $7.00 per share.
Sign-up for Amphastar Pharmaceuticals Announces Exercise of Over-Allotment Option investment picks
RANCHO CUCAMONGA, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH) , a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and inhalation products, today announced the pricing of its initial public offering of 8,000,000 shares of its common stock, including 3,360,000 shares from the selling stockholder named in the registration statement, at an initial public offering price of $7.00 per share for a total offering amount of $56,000,000 before deducting underwriting discounts and commissions, and estimated offering expenses payable by Amphastar.
Sign-up for Amphastar Pharmaceuticals Announces Pricing of Initial Public Offering investment picks
RANCHO CUCAMONGA, Calif., Aug.
Sign-up for Amphastar Pharmaceuticals Reports Revenues of $49.0 Million for the Second Quarter Ended June 30, 2014 investment picks
RANCHO CUCAMONGA, Calif., Aug.
Sign-up for Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 12, 2014 investment picks
Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved a two-for-one stock split to be paid in the form of a stock dividend.
Sign-up for Amphenol Announces Two-for-One Stock Split investment picks
Amphenol Corporation (NYSE:APH) announced today the pricing of its offering of $375 million senior notes due 2017 (the “2017 Notes”) and $375 million senior notes due 2021 (the “2021 Notes” and together with the 2017 Notes, the “Notes”). The 2017 Notes will have an interest rate of 1.550% and the 2021 Notes will have an interest rate of 3.125% per annum.
Sign-up for Amphenol Corporation Announces Pricing of $750 Million of Senior Notes investment picks
Amphenol Corporation (NYSE:APH) announced today that it has entered into a definitive agreement to acquire the Casco Automotive Group (CASCO), a division of Cap-Con Automotive Technologies Ltd.
Sign-up for Amphenol Corporation to Acquire Casco Automotive Group investment picks
2014/9/15
ENGLEWOOD, Colo., Sept.
Sign-up for Ampio Pharmaceuticals Announces Webcast for Annual Shareholder Meeting investment picks
2014/6/26
AmREIT, Inc., a Houston based real estate company that has elected to be taxed as a real estate investment trust, will announce its second quarter 2014 earnings in a press release to be issued on Tuesday, July 29, 2014 after the market closes.
Sign-up for AmREIT Announces Second Quarter 2014 Earnings Release Date and Conference Call Information investment picks
2014/7/10
AmREIT, Inc., confirmed today that it received an unsolicited, preliminary, non-binding proposal dated today’s date from Regency Centers Corporation to acquire all the outstanding shares of the Company’s common stock for $22.00 per share in cash and/or stock of Regency.
Sign-up for AmREIT Confirms Receipt of Unsolicited Proposal From Regency Centers investment picks
2014/8/25
AmREIT, Inc., announced today that it has completed the acquisition of Tuxedo Festival Shopping Center, a 54,643 square foot shopping center located on 3.96 acres in the Buckhead submarket of Atlanta, Georgia.
Sign-up for AmREIT Expands Its Portfolio of Irreplaceable Corners in Atlanta with the Acquisition of Tuxedo Festival Shopping Center investment picks
AmREIT, Inc. (NYSE: AMRE) (“AmREIT” or the “Company”) today announced financial results for the second quarter ended June 30, 2014 and declared dividends for the third quarter ending September 30, 2014.
Sign-up for AmREIT Reports Second Quarter Results and Declares September 2014 Dividend investment picks
AmREIT, Inc. (NYSE: AMRE) today announced that it has retained Jefferies LLC as financial advisor to assist the AmREIT Board of Directors in evaluating the recent unsolicited acquisition proposal from Regency Centers Corporation.
Sign-up for AmREIT Retains Financial and Legal Advisors investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of AmREIT, Inc. (“AmREIT”) (NYSE: AMRE) concerning the acquisition by Regency Centers.
Sign-up for AmREIT Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Regency Centers investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AMN Healthcare to Host 2014 Second Quarter Earnings Conference Call on Thursday, July 31, 2014 to AmREIT Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Regency Centers
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices